Bookmark
Forward
Trial watch: HIV integrase inhibitor-based regimen beats market leader.
Sarah Crunkhorn
Nature reviews. Drug discovery 2012 Sep
Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Sarah Crunkhorn.
Trial watch: HIV integrase inhibitor-based regimen beats market leader.
Nature reviews. Drug discovery.
2012 Sep;11(9):664
Mesh Tags
Clinical Trials, Phase III as Topic
HIV Infections
HIV Integrase
HIV Integrase Inhibitors
HIV-1
Humans
Substances
HIV Integrase Inhibitors
HIV Integrase
PMID: 22935794
View Full Text